Delivery Order SPE2DB24D3013-SPE2DB25FFHLA

Award Date 12/18/24
Potential Completion Date 12/19/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFHLA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,911.04, is for the delivery of OPZELURA 1.5% Cream 60GM, a pharmaceutical product. The contract has a completion date of December 19, 2024 and is a firm-fixed-price contract.

AmerisourceBergen Drug Corp is the prime contractor for this award and the company is registered in the System for Award Management (SAM.gov) through June 11, 2025. The contract does not have a set-aside designation, indicating it was open to full and open competition.

In addition to this specific delivery order, AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 3/19/25, 9:42 AM